Elanco Animal Health Incorporated (ELAN)

USD 9.18

(3.21%)

Gross Profit Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual gross profit in 2023 was 2.48 Billion USD , down -0.76% from previous year.
Elanco Animal Health Incorporated's latest quarterly gross profit in 2024 Q2 was 558 Million USD , down -19.13% from previous quarter.
Elanco Animal Health Incorporated reported a annual gross profit of 2.5 Billion USD in annual gross profit 2022, down -4.79% from previous year.
Elanco Animal Health Incorporated reported a annual gross profit of 2.63 Billion USD in annual gross profit 2021, up 63.75% from previous year.
Elanco Animal Health Incorporated reported a quarterly gross profit of 558 Million USD for 2024 Q2, down -19.13% from previous quarter.
Elanco Animal Health Incorporated reported a quarterly gross profit of 623 Million USD for 2023 Q2, down -18.35% from previous quarter.

Annual Gross Profit Chart of Elanco Animal Health Incorporated (2023 - 2015)

Historical Annual Gross Profit of Elanco Animal Health Incorporated (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	2.48 Billion USD	-0.76%
2022	2.5 Billion USD	-4.79%
2021	2.63 Billion USD	63.75%
2020	1.6 Billion USD	0.37%
2019	1.6 Billion USD	7.21%
2018	1.49 Billion USD	7.02%
2017	1.39 Billion USD	-7.27%
2016	1.5 Billion USD	9.39%
2015	1.37 Billion USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	690 Million USD	32.95%
2024 Q2	558 Million USD	-19.13%
2023 Q2	623 Million USD	-18.35%
2023 Q4	519 Million USD	-10.67%
2023 FY	2.48 Billion USD	-0.76%
2023 Q3	581 Million USD	-6.74%
2023 Q1	763 Million USD	41.3%
2022 Q4	540 Million USD	-2.88%
2022 FY	2.5 Billion USD	-4.79%
2022 Q3	556 Million USD	-19.77%
2022 Q2	693 Million USD	-3.21%
2022 Q1	716 Million USD	19.13%
2021 Q3	629 Million USD	-13.6%
2021 FY	2.63 Billion USD	63.75%
2021 Q4	601 Million USD	-4.45%
2021 Q1	673 Million USD	23.83%
2021 Q2	728 Million USD	8.17%
2020 Q3	447.8 Million USD	54.2%
2020 Q4	543.5 Million USD	21.37%
2020 FY	1.6 Billion USD	0.37%
2020 Q1	325 Million USD	-13.77%
2020 Q2	290.4 Million USD	-10.65%
2019 Q4	376.9 Million USD	-8.27%
2019 Q3	410.9 Million USD	-3.45%
2019 Q2	425.6 Million USD	9.89%
2019 FY	1.6 Billion USD	7.21%
2019 Q1	387.3 Million USD	0.13%
2018 Q4	386.8 Million USD	-1.15%
2018 FY	1.49 Billion USD	7.02%
2018 Q3	391.3 Million USD	15.53%
2018 Q2	338.7 Million USD	-9.97%
2018 Q1	376.2 Million USD	7.7%
2017 Q1	375.7 Million USD	0.0%
2017 Q4	349.3 Million USD	8.85%
2017 Q2	375.7 Million USD	0.0%
2017 Q3	320.9 Million USD	-14.59%
2017 FY	1.39 Billion USD	-7.27%
2016 FY	1.5 Billion USD	9.39%
2015 FY	1.37 Billion USD	0.0%

Peer Gross Profit Comparison of Elanco Animal Health Incorporated

Name	Gross Profit	Gross Profit Difference
Amneal Pharmaceuticals, Inc.	820.56 Million USD	-202.962%
Bausch Health Companies Inc.	6.19 Billion USD	59.89%
Catalent, Inc.	953 Million USD	-160.86%
Emergent BioSolutions Inc.	343.9 Million USD	-622.885%
Perrigo Company plc	1.68 Billion USD	-47.941%
Teva Pharmaceutical Industries Limited	7.64 Billion USD	67.486%
Zoetis Inc.	5.83 Billion USD	57.388%